88 related articles for article (PubMed ID: 10222238)
1. An early S phase checkpoint is regulated by the E2F1 transcription factor.
Stubbs MC; Strachan GD; Hall DJ
Biochem Biophys Res Commun; 1999 Apr; 258(1):77-80. PubMed ID: 10222238
[TBL] [Abstract][Full Text] [Related]
2. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
Logan TJ; Evans DL; Mercer WE; Bjornsti MA; Hall DJ
Cancer Res; 1995 Jul; 55(13):2883-91. PubMed ID: 7540951
[TBL] [Abstract][Full Text] [Related]
3. Reduction in fibronectin expression and alteration in cell morphology are coincident in NIH3T3 cells expressing a mutant E2F1 transcription factor.
Jordan-Sciutto KL; Logan TJ; Norton PA; Derfoul A; Dodge GR; Hall DJ
Exp Cell Res; 1997 Nov; 236(2):527-36. PubMed ID: 9367638
[TBL] [Abstract][Full Text] [Related]
4. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
6. A mutant E2F-1 transcription factor that affects the phenotype of NIH3T3 fibroblasts inefficiency associates with cyclin A-cdk2.
Jordan-Sciutto KL; Hall DJ
Biochem Cell Biol; 1998; 76(1):37-44. PubMed ID: 9666304
[TBL] [Abstract][Full Text] [Related]
7. In human salivary gland cells, overexpression of E2F1 overcomes an interferon-gamma- and tumor necrosis factor-alpha-induced growth arrest but does not result in complete mitosis.
Lillibridge CD; O'Connell BC
J Cell Physiol; 1997 Sep; 172(3):343-50. PubMed ID: 9284954
[TBL] [Abstract][Full Text] [Related]
8. Isolation of two novel cDNAs whose products associate with the amino terminus of the E2F1 transcription factor.
Jordan KL; Evans DL; Steelman S; Hall DJ
Biochemistry; 1996 Sep; 35(38):12320-8. PubMed ID: 8823166
[TBL] [Abstract][Full Text] [Related]
9. Altered cell shape is linked to increased p34cdc2 gene expression in fibroblasts expressing a mutant E2F-1 transcription factor.
Logan TJ; Jordan KL; Evans DL; Hall DJ
J Cell Biochem; 1997 Apr; 65(1):83-94. PubMed ID: 9138083
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
Lomazzi M; Moroni MC; Jensen MR; Frittoli E; Helin K
Nat Genet; 2002 Jun; 31(2):190-4. PubMed ID: 11992123
[TBL] [Abstract][Full Text] [Related]
11. The amino-terminus of the E2F-1 transcription factor inhibits DNA replication of autonomously replicating plasmids in mammalian cells.
Stubbs MC; Hall DJ
Oncogene; 2002 May; 21(23):3715-26. PubMed ID: 12032840
[TBL] [Abstract][Full Text] [Related]
12. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
Chew YP; Ellis M; Wilkie S; Mittnacht S
Oncogene; 1998 Oct; 17(17):2177-86. PubMed ID: 9811449
[TBL] [Abstract][Full Text] [Related]
13. Role for E2F in DNA damage-induced entry of cells into S phase.
Huang Y; Ishiko T; Nakada S; Utsugisawa T; Kato T; Yuan ZM
Cancer Res; 1997 Sep; 57(17):3640-3. PubMed ID: 9288762
[TBL] [Abstract][Full Text] [Related]
14. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
[TBL] [Abstract][Full Text] [Related]
15. Differential cell cycle effects induced by E2F1 mutants.
Qin XQ; Barsoum J
Oncogene; 1997 Jan; 14(1):53-62. PubMed ID: 9010232
[TBL] [Abstract][Full Text] [Related]
16. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
17. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells.
Chen ZY; Istfan NW
Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):67-73. PubMed ID: 11161587
[TBL] [Abstract][Full Text] [Related]
19. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
20. Gamma-irradiation-induced cell cycle arrest and cell death in a human submandibular gland cell line: effect of E2F1 expression.
O'Connell AC; Lillibridge CD; Zheng C; Baum BJ; O'Connell BC; Ambudkar IS
J Cell Physiol; 1998 Nov; 177(2):264-73. PubMed ID: 9766523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
